过去一年中添加的文章，按日期排序

Novel SERD Yields Favorable Safety in ER+/HER2–Advanced Breast Cancer.

A Wahner - Cancer Network, 2023 - go.gale.com
177 天前 - … in combination with palbociclib (Ibrance) or everolimus (Afinitor). Disclosure: Zhang
has … or metastatic breast cancer. Presented at: 2023 San Antonio Breast Cancer Symposium…
相关文章